Osaic Holdings’s Anika Therapeutics ANIK Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $164 | Hold |
10
| – | – | ﹤0.01% | 7011 |
|
|
2025
Q1 | $150 | Hold |
10
| – | – | ﹤0.01% | 7020 |
|
|
2024
Q4 | $164 | Hold |
10
| – | – | ﹤0.01% | 7009 |
|
|
2024
Q3 | $247 | Hold |
10
| – | – | ﹤0.01% | 6922 |
|
|
2024
Q2 | $253 | Hold |
10
| – | – | ﹤0.01% | 6923 |
|
|
2024
Q1 | $254 | Sell |
10
-56,853
| -100% | -$1.44M | ﹤0.01% | 6749 |
|
|
2023
Q4 | $1.29M | Sell |
56,863
-1,662
| -3% | -$37.7K | ﹤0.01% | 2254 |
|
|
2023
Q3 | $1.09M | Buy |
58,525
+58,490
| +167,114% | +$1.09M | ﹤0.01% | 2561 |
|
|
2023
Q2 | $907 | Sell |
35
-38
| -52% | -$985 | ﹤0.01% | 6766 |
|
|
2023
Q1 | $2.1K | Buy |
73
+2
| +3% | +$57 | ﹤0.01% | 6589 |
|
|
2022
Q4 | $2K | Sell |
71
-7,482
| -99% | -$211K | ﹤0.01% | 6554 |
|
|
2022
Q3 | $180K | Buy |
7,553
+1,767
| +31% | +$42.1K | ﹤0.01% | 3847 |
|
|
2022
Q2 | $129K | Buy |
5,786
+3,828
| +196% | +$85.3K | ﹤0.01% | 4189 |
|
|
2022
Q1 | $49K | Buy |
1,958
+148
| +8% | +$3.7K | ﹤0.01% | 5087 |
|
|
2021
Q4 | $64K | Buy |
1,810
+158
| +10% | +$5.59K | ﹤0.01% | 4942 |
|
|
2021
Q3 | $69K | Buy |
1,652
+1,038
| +169% | +$43.4K | ﹤0.01% | 4843 |
|
|
2021
Q2 | $26K | Buy |
614
+576
| +1,516% | +$24.4K | ﹤0.01% | 5473 |
|
|
2021
Q1 | $1K | Sell |
38
-1,512
| -98% | -$39.8K | ﹤0.01% | 6520 |
|
|
2020
Q4 | $69K | Buy |
1,550
+1,180
| +319% | +$52.5K | ﹤0.01% | 4310 |
|
|
2020
Q3 | $13K | Buy |
370
+14
| +4% | +$492 | ﹤0.01% | 5115 |
|
|
2020
Q2 | $13K | Sell |
356
-130
| -27% | -$4.75K | ﹤0.01% | 4991 |
|
|
2020
Q1 | $15K | Buy |
+486
| New | +$15K | ﹤0.01% | 4744 |
|